Test Code DIG Digoxin
Additional Codes
| EPIC | LAB4077 |
Synonyms
- Lanoxin
Clinical Significance
Digoxin is administered for the treatment of congestive heart failure and certain types of cardiac arrhythmias. It is monitored for possible toxicity and as a guide for acute and maintenance therapy.
Source: Beckman Coulter Unicel, DIGN IFU. REF #650182 4/29/15
Methodology
Particle enhanced turbidimetric inhibition immunoassay (Beckman Coulter UniCel DxC 660i)
Sample Type
| Preferred Sample Type | |
|---|---|
| Light green top - Plasma | |
| Acceptable Sample Type(s) | |
|---|---|
| Dark green top - Plasma | |
| Yellow top - Serum | |
| Red top - Serum | |
Centrifuge: Yes
Specimen Minimum Volume
0.3 mL
Specimen Stability
| Temperature | Time |
|---|---|
| Ambient (18-25°C) | 8 hours |
| Refrigerated (2-8°C) (store) | 48 hours |
| Frozen (-15 to -20°C) | 1 month |
Separate plasma or serum from cells within 2 hours.
Reference Ranges
| Therapeutic Range |
|---|
| 0.8 - 1.5 ng/mL |
| Critical Value |
|---|
| >2.5 ng/mL |
| Technical Range |
|---|
| 0.2 - 4.5 ng/mL |
Rejection Criteria
| Hemolysis | N/A |
|---|---|
| Icterus | N/A |
| Lipemia | N/A |
Availability
| Performed | STAT |
|---|---|
| 24/7 | Yes |
Performing Laboratory
MultiCare Yakima Memorial Hospital Laboratory
Lab Department
Chemistry
CPT Code
80162
LOINC
10535-3 Digoxin [Mass/Vol]